Genomic Vision (Germany) Technical Analysis

G09 Stock  EUR 707.37  3.80  0.53%   
As of the 29th of November, Genomic Vision retains the Market Risk Adjusted Performance of 0.1445, risk adjusted performance of 0.033, and Downside Deviation of 1.21. Genomic Vision technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genomic Vision Socit standard deviation, information ratio, treynor ratio, as well as the relationship between the variance and jensen alpha to decide if Genomic Vision is priced fairly, providing market reflects its last-minute price of 707.37 per share.

Genomic Vision Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Genomic, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Genomic
  
Genomic Vision's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Genomic Vision technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Genomic Vision technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genomic Vision trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Genomic Vision Socit Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Genomic Vision Socit volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Genomic Vision Socit Trend Analysis

Use this graph to draw trend lines for Genomic Vision Socit. You can use it to identify possible trend reversals for Genomic Vision as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Genomic Vision price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Genomic Vision Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Genomic Vision Socit applied against its price change over selected period. The best fit line has a slop of   0.52  , which means Genomic Vision Socit will continue generating value for investors. It has 122 observation points and a regression sum of squares at 10310.82, which is the sum of squared deviations for the predicted Genomic Vision price change compared to its average price change.

About Genomic Vision Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genomic Vision Socit on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genomic Vision Socit based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genomic Vision Socit price pattern first instead of the macroeconomic environment surrounding Genomic Vision Socit. By analyzing Genomic Vision's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genomic Vision's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genomic Vision specific price patterns or momentum indicators. Please read more on our technical analysis page.

Genomic Vision November 29, 2024 Technical Indicators

Most technical analysis of Genomic help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genomic from various momentum indicators to cycle indicators. When you analyze Genomic charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Genomic Vision November 29, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Genomic stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Genomic Stock analysis

When running Genomic Vision's price analysis, check to measure Genomic Vision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomic Vision is operating at the current time. Most of Genomic Vision's value examination focuses on studying past and present price action to predict the probability of Genomic Vision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomic Vision's price. Additionally, you may evaluate how the addition of Genomic Vision to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals